This slide show features images of diffuse osteoblastic bone metastases in a 70-year-old advanced prostate cancer patient, bone metastases in the vertebral column of a kidney cancer patient, and more.
Talazoparib/Enzalutamide Improves Survival Vs Placebo in HRR mCRPC
June 4th 2023Talazoparib plus enzalutamide appears to improve the objective response rate vs enzalutamide plus placebo among patients with metastatic castration-resistant prostate cancer harboring homologous recombination repair mutations in the phase 3 TALAPRO-2 study.
Radium-223 Can Be ‘Integrated into Treatment Sequencing’ in Metastatic CRPC
June 3rd 2023According to an expert from Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, radium-223 shows positive efficacy and safety findings for patients with metastatic castration-resistant prostate cancer.
2 Clarke Drive
Cranbury, NJ 08512